Authors: Friedman, HS Keir, ST Houghton, PJ Lawless, AA Bigner, DD Waters, SJ

Citation: Hs. Friedman et al., Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice, CANC CHEMOT, 48(5), 2001, pp. 413-416

Authors: Wang, WX Waters, SJ Macdonald, JR Von Hoff, DD Strodel, WE Miller, AR

Citation: Wx. Wang et al., Irofulven (6-hydroxymethylacylfulvene, MGI 114) induces caspase 8 and 9-mediated apoptosis in human pancreatic adenocarcinoma cells, ANTICANC R, 21(3B), 2001, pp. 1789-1794

Authors: Woynarowska, BA Higdon, AL Munoz, RM Bushong, P Waters, SJ

Citation: Ba. Woynarowska et al., Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven, INV NEW DR, 19(4), 2001, pp. 283-291

Authors: McMorris, TC Yu, J Lira, R Dawe, R MacDonald, JR Waters, SJ Estes, LA Kelner, MJ

Citation: Tc. Mcmorris et al., Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analogues, J ORG CHEM, 66(18), 2001, pp. 6158-6163

Authors: Hess, TM Waters, SJ Bolstad, CA

Citation: Tm. Hess et al., Motivational and cognitive influences on affective priming in adulthood, J GERONT B, 55(4), 2000, pp. P193-P204

Authors: Weitman, S Barrera, H Moore, R Gonzalez, C Marty, J Hilsenbeck, S MacDonald, JR Waters, SJ Von Hoff, D

Citation: S. Weitman et al., MGI 114: Augmentation of antitumor activity when combined with topotecan, J PED H ONC, 22(4), 2000, pp. 306-314